Fulgent Genetics (FLGT) Free Cash Flow Growth (1y) (2016 - 2026)
Fulgent Genetics (FLGT) Free Cash Flow Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 51.58% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 16.06% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 112.68% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 87.85% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 23.29% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -20.33% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -21.08% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 33.01% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 5.28% |
| 10 | Fulgent Genetics | 518.37 Mn | 261.34 Mn | 25.68 Mn | 25.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.36% |
| Mar 31, 2026 | 120.71% |
| Dec 31, 2025 | -670.13% |
| Sep 30, 2025 | 187.91% |
| Jun 30, 2025 | -887.91% |
| Mar 31, 2025 | -385.02% |
| Dec 31, 2024 | -208.30% |
| Sep 30, 2024 | -348.52% |
| Jun 30, 2024 | 247.82% |
| Mar 31, 2024 | 132.29% |
| Dec 31, 2023 | -58.48% |
| Sep 30, 2023 | -65.34% |
| Jun 30, 2023 | -130.59% |
| Mar 31, 2023 | -105.43% |
| Dec 31, 2022 | -59.94% |
| Sep 30, 2022 | -89.69% |
| Jun 30, 2022 | -89.25% |
| Mar 31, 2022 | -17.43% |
| Dec 31, 2021 | -35.63% |
| Sep 30, 2021 | 20,940.20% |